

Kee Pharma Profile
Key Indicators
- Authorised Capital ₹ 11.00 Cr
- Paid Up Capital ₹ 10.48 Cr
- Company Age 33 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.50 Cr
- Satisfied Charges ₹ 4.50 Cr
- Revenue Growth -2.77%
- Profit Growth -2086.45%
- Ebitda -295.44%
- Net Worth -35.80%
- Total Assets -0.84%
About Kee Pharma
Kee Pharma Limited (KPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 08 May 1991 and has a history of 33 years and 11 months. Its registered office is in Delhi, India.
The Corporate was formerly known as Kee Pharma P Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 11.00 Cr and a paid-up capital of Rs 10.48 Cr.
The company currently has active open charges totaling ₹9.50 Cr. The company has closed loans amounting to ₹4.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Kee Pharma Limited India are Anil Motihar as CFO and Manoj Mishra as Company Secretary. Anil Motihar, Harinder Motihar, and Varun Motihar serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24239DL1991PLC044264
- Company No.
044264
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 May 1991
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Kee Pharma Limited offer?
Kee Pharma Limited offers a wide range of products and services, including Sexual Wellness Products, Fertility Enhancer, Respiratory System Drugs, Anti Asthma Drug, Herbal Cough Syrup, Ayurvedic Cough Syrup, Ayurvedic Herbal Syrups & Tonics, Diclofenac, Diclofenac Potassium Tablets.
Who are the key members and board of directors at Kee Pharma?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Anil Motihar ![]() | Managing Director | 09-Nov-1992 | Current |
Manoj Mishra | Company Secretary | 15-Nov-2009 | Current |
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Harinder Motihar ![]() | Director | 24-Jun-2006 | Current |
Varun Motihar ![]() | Director | 11-Dec-2014 | Current |
Financial Performance of Kee Pharma.
Kee Pharma Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.77% decrease. The company also saw a substantial fall in profitability, with a 2086.45% decrease in profit. The company's net worth observed a substantial decline by a decrease of 35.8%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Kee Pharma?
In 2023, Kee Pharma had a promoter holding of 84.65% and a public holding of 15.35%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Kee Healthcare Private Limited
Anil Motihar is a mutual person
- Kee Diagnostics Private Limited
Anil Motihar is a mutual person
- Helvetica Industries Private Limited
Anil Motihar is a mutual person
Charges (Loans)
₹9.50 Cr
₹4.50 Cr
Charges Breakdown by Lending Institutions
- Indian Bank : 5.80 Cr
- Nidian Bank : 1.80 Cr
- Hsidc : 0.96 Cr
- Haryana State Industrial Development Cor. Ltd. : 0.90 Cr
- Ge Capital Services India : 0.05 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
07 Oct 2004 | Indian Bank | ₹2.95 Cr | Open |
11 Sep 2003 | Ge Capital Services India | ₹0.45 M | Open |
18 Oct 2002 | Nidian Bank | ₹7.50 M | Open |
20 Oct 2000 | Nidian Bank | ₹1.00 Cr | Open |
26 Dec 1999 | Indian Bank | ₹0.80 M | Open |
How Many Employees Work at Kee Pharma?
Kee Pharma has a workforce of 222 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Kee Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kee Pharma's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Kee Pharma
Recent activity within the organization
- Annual General Meeting
Kee Pharma Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Kee Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
- Director Appointment
Anil Motihar was appointed as a Cfo was appointed as a Cfo on 03 Apr 2019 & has been associated with this company since 6 years 8 days .
- Director Appointment
Varun Motihar was appointed as a Director was appointed as a Director on 11 Dec 2014 & has been associated with this company since 10 years 4 months .
- Charges
A charge registered on 04 Nov 2008 via Charge ID 10135284 with State Bank Of India was fully satisfied on 12 Oct 2010.
- Director Appointment
Manoj Kumar Mishra was appointed as a Company Secretary was appointed as a Company Secretary on 15 Nov 2009 & has been associated with this company since 15 years 4 months .
Frequently asked questions
What is the Incorporation or founding date of Kee Pharma Limited?
Kee Pharma Limited was incorporated on 08 May 1991.
What is authorized share capital and paid-up capital of Kee Pharma Limited?
The authorized share capital of Kee Pharma Limited is ₹ 11.00 Cr and paid-up capital is ₹ 10.48 Cr.
Who are the current board members & directors of Kee Pharma Limited?
Currently 5 directors are associated with Kee Pharma Limited.
- Anil Motihar
- Harinder Motihar
- Varun Motihar
- Anil Motihar
- Manoj Kumar Mishra
What is the registered address of Kee Pharma Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Kee Pharma Limited is A - 8 3Rd Floor Naraina Industrial Area Phase Ii, India, New Delhi, 110028.
What is the corporate identification number (CIN) and company number of Kee Pharma Limited?
The corporate identification number (CIN) of Kee Pharma Limited is U24239DL1991PLC044264 and the company number is 044264 as per Ministry of Corporate Affairs (MCA).
What is the official website of Kee Pharma Limited?
The Official website of Kee Pharma Limited is https://www.keepharma.com
What has been the recent revenue trend for Kee Pharma Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Kee Pharma Limited has fallen by -2.77%.
How many employees does Kee Pharma Limited currently have?
As Per 2023 financial reports, 222 employees are currently employed by Kee Pharma Limited.
What change has been observed in the net worth of Kee Pharma Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Kee Pharma Limited has experienced an downturn of -35.80%.
What are the total open charges for Kee Pharma Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Kee Pharma Limited amount to ₹ 9.50 Cr.
When was the last Balance Sheet of Kee Pharma Limited filed with the ROC?
The most recent Balance Sheet for Kee Pharma Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
- Kapil KohliDirector
AB
Ajit BhaskarDirector
Similar Companies Based on Drug Formulation & Development
- Mylan Laboratories Limited Hyderabad, Telangana, India
- Sun Pharma Laboratories Limited Vadodara, Gujarat, India
- Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
- Lupin Limited Mumbai, Maharashtra, India
- Alkem Laboratories Limited Mumbai, Maharashtra, India
- Hetero Labs Limited Rangareddy, Telangana, India
- Aurobindo Pharma Ltd Hyderabad, Telangana, India
- Cipla Limited Mumbai, Maharashtra, India